Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27619,103,2.84 [1.82-4.43],4.330668880298413e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28191,143,1.22 [0.82-1.82],0.3258475348839212
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27938,1009,1.24 [1.07-1.45],0.0045817920471571
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Candidiasis,28224,308,1.23 [0.94-1.61],0.1348687692142164
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,27430,2772,1.21 [1.10-1.32],5.425422923025884e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27687,2092,1.30 [1.17-1.45],7.876532631731187e-07
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,28011,998,1.27 [1.09-1.47],0.002126443179233
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,28139,43,3.40 [1.74-6.64],0.0003343589076187
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26946,642,1.68 [1.39-2.03],9.6796430251421e-08
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,26061,622,1.85 [1.53-2.25],2.8217205009137647e-10
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,26307,175,1.34 [0.93-1.93],0.1209359628063807
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,21025,1219,1.18 [1.03-1.36],0.0180188032113205
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26065,286,1.95 [1.47-2.58],3.320989355086601e-06
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,28176,1163,1.22 [1.06-1.40],0.006170442439429
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Mycoses,28286,370,1.12 [0.87-1.43],0.3839810404246722
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27539,610,1.49 [1.23-1.80],5.534557810874144e-05
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,28223,707,1.68 [1.40-2.00],1.409995670040814e-08
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27158,145,1.16 [0.78-1.73],0.4544919362073629
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,28327,32,1.64 [0.71-3.77],0.2473069442087756
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other septicaemia,28137,621,1.68 [1.39-2.03],1.0181753129826149e-07
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28167,71,0.90 [0.51-1.59],0.7115929422050282
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28233,172,1.78 [1.25-2.55],0.0015640145651349
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28217,156,1.73 [1.19-2.52],0.0043252292207322
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27265,336,1.23 [0.95-1.60],0.1187856422126494
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,27177,248,1.12 [0.83-1.52],0.4650347389219629
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,27095,82,1.84 [1.10-3.08],0.0203777705402891
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,28298,52,1.58 [0.84-3.00],0.1591021431497609
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28263,129,1.33 [0.88-2.02],0.1771885442728313
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Viral warts,28177,43,1.32 [0.64-2.72],0.452560281319744
CD300LG,CMRF35-like molecule 9,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],28184,50,1.01 [0.51-1.97],0.9861363952420896
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm,28030,321,0.99 [0.75-1.29],0.9214629879588548
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28234,76,1.31 [0.76-2.26],0.3237988806935993
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28213,80,0.89 [0.52-1.53],0.6766219386903604
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12631,45,0.83 [0.40-1.73],0.6139973338083642
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",28130,1204,0.94 [0.82-1.08],0.3868632399290712
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of meninges,28315,50,0.62 [0.32-1.23],0.1735877326842099
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28291,51,0.49 [0.25-0.96],0.0388094127777652
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,28304,96,0.87 [0.53-1.41],0.5648464802907587
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm of ovary,15633,101,0.89 [0.55-1.42],0.6227599741512921
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Ascending colon,28321,279,1.16 [0.87-1.55],0.3074958710727877
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Caecum,28316,210,1.01 [0.72-1.41],0.9603217118333248
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28257,59,0.79 [0.42-1.48],0.4655345131640105
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Descending colon,28320,178,0.84 [0.59-1.22],0.3632260993802827
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Rectum,28284,299,0.87 [0.66-1.15],0.3407060303064719
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28251,552,1.02 [0.83-1.25],0.8706664133997792
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Benign neoplasm: Transverse colon,28321,320,0.78 [0.59-1.02],0.0672737823157109
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Carcinoma in situ of breast,13449,89,1.04 [0.63-1.73],0.8674579751886694
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13496,100,0.81 [0.50-1.31],0.3971878156831655
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24476,30,2.03 [0.85-4.87],0.1112088963797761
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24483,37,1.57 [0.72-3.43],0.2605407300050475
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28285,112,0.50 [0.32-0.78],0.0023628438002044
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Haemangioma, any site",28285,110,0.48 [0.30-0.76],0.0015379259791306
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Leiomyoma of uterus,14985,426,0.62 [0.49-0.78],4.564019425060077e-05
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lung cancer and mesothelioma,21058,181,0.65 [0.46-0.94],0.0202324503328251
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Lymphoid leukaemia,24475,29,1.18 [0.48-2.89],0.7125310224585306
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24599,153,1.36 [0.92-2.02],0.1201114825742072
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24534,88,1.40 [0.84-2.34],0.1990518010388179
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13553,85,0.80 [0.48-1.35],0.4102774465648604
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24498,52,1.60 [0.83-3.11],0.1632724889252611
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24515,69,1.48 [0.83-2.66],0.1845832657842022
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24518,72,0.79 [0.44-1.42],0.4375635104146088
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13524,56,1.15 [0.61-2.17],0.6598362033202219
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24502,56,1.06 [0.56-2.03],0.8514371049928688
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11395,417,0.94 [0.74-1.20],0.6326465158649179
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24539,93,1.08 [0.66-1.79],0.7532309598882132
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24502,56,0.80 [0.42-1.55],0.513739459148859
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24511,65,1.86 [1.03-3.37],0.0396060416014865
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi,28081,221,1.18 [0.86-1.63],0.3063292111565983
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanocytic naevi of trunk,28274,98,1.32 [0.82-2.15],0.2571417841305316
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Melanoma in situ,24462,53,0.85 [0.43-1.64],0.6202752291512351
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24503,57,1.64 [0.87-3.08],0.1258853107802375
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24565,119,1.20 [0.77-1.87],0.4154178533709851
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24568,122,0.57 [0.37-0.88],0.0114377804210836
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24514,68,1.53 [0.86-2.73],0.1505076591677674
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,Other benign neoplasms of skin,28142,147,1.05 [0.70-1.55],0.8252541192514452
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",25109,663,1.32 [1.09-1.59],0.0042597517676421
CD300LG,CMRF35-like molecule 9,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",25141,695,1.37 [1.14-1.64],0.0008784828876905
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28048,287,1.58 [1.20-2.09],0.0013045383274163
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26877,57,7.42 [4.32-12.74],3.586119676848113e-13
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27833,72,1.82 [1.05-3.18],0.0343900063436701
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27511,2278,1.19 [1.08-1.32],0.000638621028742
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,27117,25,1.85 [0.72-4.79],0.2044890586392573
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27967,36,1.75 [0.80-3.82],0.1632878690357052
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27878,1058,1.52 [1.32-1.76],1.8811170215549173e-08
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27878,1058,1.52 [1.32-1.76],1.8811170215549173e-08
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26877,57,2.95 [1.59-5.44],0.0005571588002981
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,28038,946,1.04 [0.89-1.21],0.6525553924773374
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,28044,113,3.23 [2.11-4.94],6.21530397017579e-08
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27815,54,1.33 [0.69-2.55],0.3945188274837788
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27804,43,1.16 [0.56-2.41],0.6835669374823552
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,28128,197,1.38 [0.98-1.94],0.0625885789099995
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,28246,72,0.87 [0.50-1.53],0.6389430224136241
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",28096,165,1.53 [1.05-2.21],0.0248308560341506
CD300LG,CMRF35-like molecule 9,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,27167,75,1.24 [0.72-2.16],0.4395686799025327
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,24354,214,2.31 [1.67-3.21],5.287429882044435e-07
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,26361,128,0.60 [0.39-0.93],0.0208319698495188
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26377,144,1.22 [0.81-1.81],0.3402395441017434
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,24178,38,0.72 [0.32-1.61],0.4250156918688702
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,26300,71,1.89 [1.09-3.26],0.0231065652045106
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25959,151,1.38 [0.93-2.04],0.1104233281061764
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",28180,174,0.95 [0.66-1.37],0.7851738982323512
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,28053,47,0.83 [0.41-1.67],0.5920925221365754
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,28043,37,1.54 [0.70-3.39],0.2774540123302838
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27909,1680,0.94 [0.83-1.05],0.2772583101728369
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,25377,1630,0.91 [0.80-1.02],0.104856748485608
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",24182,42,0.54 [0.25-1.16],0.1146098780531125
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26602,56,1.29 [0.68-2.43],0.43654293567669
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,24331,191,1.47 [1.03-2.09],0.0334228247201612
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,24207,67,0.93 [0.50-1.70],0.8028594226753609
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26579,2439,0.73 [0.66-0.80],4.6029701389164254e-10
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,24257,117,1.05 [0.67-1.65],0.8386971126361153
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24534,394,1.21 [0.95-1.55],0.1249736459457388
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28224,279,1.93 [1.45-2.55],5.169279737877985e-06
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,28059,114,3.80 [2.51-5.76],2.89896819190346e-10
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,24239,99,1.53 [0.94-2.51],0.0897576909542317
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",24179,39,1.66 [0.76-3.61],0.2015783032022085
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27884,1338,1.07 [0.94-1.22],0.3193157885205334
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,24270,130,3.01 [2.00-4.55],1.4649337939665614e-07
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,24306,166,2.84 [1.97-4.10],2.4987529318928217e-08
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24537,397,0.81 [0.63-1.04],0.0991164849861099
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,24201,61,2.05 [1.10-3.80],0.0236913010586196
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,28052,107,4.11 [2.69-6.29],7.187300402970263e-11
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24443,303,1.70 [1.29-2.25],0.0001726580831677
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24439,299,1.30 [0.98-1.73],0.0647095912785303
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25864,56,1.14 [0.60-2.16],0.6977113447813669
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27628,3488,0.86 [0.79-0.93],0.0003271657962456
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26583,37,2.20 [1.03-4.71],0.0420113489366241
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26608,62,0.91 [0.50-1.68],0.774938762861131
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,28140,1970,0.98 [0.88-1.09],0.7300975738408395
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",28144,1967,0.99 [0.88-1.10],0.7960580313662342
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26585,39,1.35 [0.63-2.86],0.4380101270274498
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27997,1273,0.95 [0.83-1.08],0.4386756282158908
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",25048,908,1.49 [1.27-1.75],9.977065255589647e-07
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,28317,136,1.64 [1.10-2.44],0.0160529703459801
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,28041,35,0.85 [0.37-1.91],0.6879789011314293
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26815,91,1.34 [0.82-2.20],0.2400579277090512
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26841,117,0.56 [0.36-0.87],0.0105406217521572
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",24273,133,1.05 [0.69-1.60],0.829117033636354
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26486,123,1.21 [0.78-1.86],0.3983679181816303
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1756,72,2.41 [1.45-4.01],0.0007379714187581
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1864,195,1.84 [1.33-2.54],0.0002184991318661
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,26404,41,0.62 [0.28-1.38],0.2432898871563836
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1721,37,6.35 [3.29-12.25],3.490253637378074e-08
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27897,1534,0.48 [0.42-0.55],6.740124096892263e-30
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,28079,73,1.60 [0.92-2.79],0.095008201068937
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,26087,279,1.22 [0.92-1.61],0.1758687997957018
CD300LG,CMRF35-like molecule 9,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24558,418,1.78 [1.41-2.26],1.4310824576702298e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28237,179,2.54 [1.81-3.58],8.416024207952845e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27584,57,0.75 [0.39-1.44],0.3893387791483809
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Angina pectoris,27023,807,0.75 [0.63-0.89],0.0009264059402734
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27632,105,0.91 [0.56-1.48],0.707911468477572
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27558,31,3.86 [1.74-8.57],0.0009185749444461
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27634,107,1.55 [0.98-2.48],0.0630744668662889
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,20229,962,1.21 [1.03-1.42],0.02221358746902
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,AV-block,25790,184,1.23 [0.86-1.77],0.2630867172937331
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28295,262,1.08 [0.80-1.45],0.6176783959686993
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiac arrest,19384,117,2.14 [1.34-3.40],0.0013469847381098
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25742,136,0.92 [0.60-1.39],0.6798780601842114
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25687,81,1.01 [0.59-1.74],0.9600153641961232
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,28329,20,0.52 [0.18-1.56],0.2446399984688989
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Conduction disorders,26141,535,1.19 [0.96-1.47],0.1097902287017334
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27592,1387,0.92 [0.81-1.05],0.2034696464335121
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,26360,6176,0.82 [0.77-0.87],2.85329883713448e-10
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27144,188,2.59 [1.86-3.63],2.5241459838724724e-08
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Endocarditis,25648,42,1.49 [0.70-3.18],0.2982929162277442
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28209,525,1.26 [1.02-1.56],0.0300232998149813
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertension,26947,5029,0.75 [0.70-0.81],2.828249239476032e-15
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26962,5044,0.77 [0.72-0.82],1.1532162132287073e-13
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, portal",28156,59,2.00 [1.09-3.68],0.024679653032752
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22007,89,3.33 [1.99-5.56],4.432173182965107e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21980,62,40.14 [25.75-62.58],1.0017227484297196e-59
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Hypotension,28223,707,1.50 [1.25-1.80],8.798306456989801e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27793,65,1.19 [0.66-2.16],0.5665986385355067
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27758,1542,0.92 [0.81-1.04],0.1959134461929043
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28098,311,1.27 [0.97-1.66],0.086179096407252
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25799,193,1.17 [0.83-1.67],0.3719178786814215
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,28066,608,0.97 [0.80-1.18],0.7802788461765432
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26708,492,1.02 [0.82-1.27],0.8445592806794173
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28269,118,1.03 [0.66-1.61],0.8978791157805768
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",28313,204,0.90 [0.64-1.27],0.5552076909282588
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Oesophageal varices,26998,42,1.59 [0.75-3.36],0.227344013866922
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other aneurysm,27578,51,1.90 [0.98-3.68],0.0562495187447625
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arrhythmias,25853,247,1.21 [0.89-1.65],0.229470508099555
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27592,65,2.61 [1.47-4.61],0.0010065681803771
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27671,144,2.56 [1.74-3.76],1.5977018810723166e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25738,132,1.33 [0.88-2.03],0.1805102921875719
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other disorders of veins,27032,76,1.86 [1.08-3.18],0.0248458213511605
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,27006,50,1.67 [0.86-3.26],0.1311702996339594
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27536,39,1.83 [0.85-3.94],0.124431742572221
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,27048,92,1.71 [1.05-2.81],0.0324425361964659
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,26200,594,1.52 [1.25-1.86],3.451136469960576e-05
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27562,46,2.16 [1.08-4.33],0.0299397141734002
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27873,346,1.90 [1.48-2.44],6.361621738177181e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27879,160,2.53 [1.76-3.63],5.408333025283155e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27734,237,1.30 [0.96-1.78],0.0946566454513033
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19526,259,1.41 [1.03-1.92],0.0314103836202513
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27709,209,1.66 [1.19-2.31],0.0026722608230922
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27215,259,1.97 [1.47-2.64],6.23138533577231e-06
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28062,343,1.48 [1.14-1.91],0.0031650415627811
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28288,337,1.22 [0.94-1.59],0.1283885236391591
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25783,177,1.11 [0.77-1.61],0.5747166788320146
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27875,156,2.67 [1.86-3.85],1.328230555979969e-07
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27614,117,1.53 [0.99-2.38],0.0579302793660992
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28091,363,1.26 [0.98-1.62],0.0717876548989822
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28065,399,1.22 [0.96-1.55],0.1045650528152789
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27769,55,0.80 [0.42-1.53],0.505909269482862
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27582,56,1.34 [0.70-2.57],0.3842140620406693
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27930,143,0.94 [0.62-1.40],0.747158686891576
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27643,185,0.75 [0.53-1.08],0.1226801648038957
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Varicose veins,27282,326,1.50 [1.15-1.95],0.0028105324065203
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27536,49,0.66 [0.33-1.32],0.2401282700019744
CD300LG,CMRF35-like molecule 9,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28153,541,1.58 [1.29-1.94],1.312253559308887e-05
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28168,382,1.09 [0.85-1.40],0.482080000334984
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",25267,1461,0.96 [0.84-1.09],0.5085883890121006
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Any mental disorder,27561,3755,0.93 [0.86-1.01],0.0796660627241605
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28102,453,0.91 [0.72-1.14],0.4149620645169916
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25517,1711,0.93 [0.82-1.04],0.1981246028527085
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23899,93,1.25 [0.76-2.05],0.3801146943135265
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Smoking dependency,27777,1554,0.99 [0.87-1.11],0.8289968434269526
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25606,1800,0.93 [0.83-1.04],0.2098689771493938
CD300LG,CMRF35-like molecule 9,Chapter V Mental and behavioural disorders,Vascular dementia,28212,21,1.95 [0.69-5.45],0.2055105473109472
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Alzheimer disease,28329,65,0.99 [0.54-1.79],0.9638848360943738
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Bell's palsy,26633,74,1.73 [1.00-2.99],0.0482567695311732
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27048,489,0.84 [0.67-1.04],0.1047455765265247
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral cysts,27964,212,1.31 [0.94-1.81],0.1103835999519196
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28245,232,1.12 [0.81-1.53],0.4965687165473046
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,28187,23,1.20 [0.44-3.23],0.7248315370554018
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,28314,52,2.24 [1.18-4.25],0.0133226356917384
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27813,61,0.95 [0.51-1.77],0.8689728442239555
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Epilepsy,26721,260,1.61 [1.20-2.16],0.0013773288648649
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27838,1377,1.01 [0.89-1.15],0.8896763554500206
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,28299,274,1.08 [0.81-1.44],0.6113278962656872
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27805,1683,1.26 [1.12-1.41],0.000107808547608
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Generalized epilepsy,27953,51,1.84 [0.96-3.53],0.067266319618169
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hemiplegia,28178,165,1.55 [1.07-2.23],0.0198161376041381
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Hydrocephalus,27800,48,0.92 [0.46-1.84],0.8038565562817088
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,28305,62,1.06 [0.58-1.95],0.8441688571232885
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26641,82,0.83 [0.49-1.42],0.5017649936376017
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26648,89,1.09 [0.65-1.81],0.7457329864012048
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Memory loss,28177,74,1.09 [0.62-1.90],0.7715613958932346
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Migraine,26896,435,0.97 [0.77-1.23],0.8281585334476974
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28236,387,1.01 [0.79-1.29],0.9287858510672052
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Motor neuron disease,20642,99,0.82 [0.50-1.35],0.4314166939246204
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28130,144,0.80 [0.53-1.19],0.2719141343351089
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27714,1155,1.00 [0.87-1.15],0.9698397075640732
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Neurological diseases,26883,3147,1.02 [0.94-1.12],0.5979973958346589
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,28239,75,1.31 [0.76-2.27],0.3333616611206552
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26951,392,1.11 [0.87-1.41],0.4077716575428213
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",28259,239,1.61 [1.19-2.19],0.0021820932058739
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23639,307,0.97 [0.74-1.28],0.8444556144173063
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27814,62,1.80 [0.99-3.29],0.0547632276061456
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27870,118,1.28 [0.82-1.99],0.2731738279984255
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,28117,92,1.45 [0.88-2.37],0.1406467626868993
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26651,92,1.62 [0.99-2.64],0.056386295258142
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other headache syndromes,26521,60,1.24 [0.67-2.28],0.4976372137658669
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other neurological diseases,28204,452,1.22 [0.98-1.53],0.0774400569207856
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Other sleep disorders,27062,601,0.85 [0.69-1.03],0.1032892582118781
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Parkinson's disease,28316,164,0.95 [0.65-1.38],0.7795288842838716
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27818,66,1.36 [0.76-2.44],0.3020635967422801
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Restless leg syndrome,28328,47,2.19 [1.13-4.23],0.0199916688034548
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Sleep apnoea,28078,521,0.80 [0.65-0.99],0.043591333129829
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Small fibre neuropathy,28056,36,0.80 [0.35-1.80],0.5851248440668593
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,28313,126,0.95 [0.62-1.46],0.8186911530089874
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26591,32,1.45 [0.63-3.36],0.3817197042775189
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,28329,66,0.97 [0.54-1.74],0.906596520093966
CD300LG,CMRF35-like molecule 9,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),28200,20,2.32 [0.82-6.57],0.1147117691738855
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27840,42,1.04 [0.50-2.17],0.9239651462623508
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27974,221,0.93 [0.67-1.28],0.6551149642946053
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28239,198,1.14 [0.80-1.60],0.4691395447614672
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27567,38,0.99 [0.46-2.15],0.9765787208311918
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27604,75,0.58 [0.33-1.01],0.053996621484253
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",28237,32,0.91 [0.39-2.13],0.8360312637088
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,28126,65,1.04 [0.57-1.89],0.88833800661656
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1728,44,8.22 [4.63-14.59],6.322398611585433e-13
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2039,89,2.88 [1.90-4.35],5.6604292110107e-07
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27874,76,1.23 [0.71-2.13],0.455810007218569
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,28196,636,0.97 [0.80-1.18],0.7741451922757736
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28017,488,0.98 [0.79-1.21],0.8389817986590942
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27668,139,1.51 [1.01-2.26],0.0423738444155828
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28234,481,1.10 [0.88-1.37],0.4046926849470619
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,28316,54,1.44 [0.75-2.76],0.2687766330039033
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,28162,409,1.06 [0.84-1.34],0.6329737148815895
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",28284,223,1.13 [0.82-1.56],0.4589208914325435
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,28263,129,1.04 [0.68-1.59],0.8573923729775951
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27547,18,2.10 [0.69-6.38],0.1897987145589315
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27558,29,0.63 [0.25-1.55],0.3102013466465696
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27561,32,1.19 [0.51-2.77],0.6877721169345377
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28279,389,1.01 [0.79-1.29],0.9285917024456098
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27990,100,0.85 [0.53-1.37],0.5072131129093987
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27778,25,1.55 [0.60-4.01],0.3687627665166492
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,28134,73,1.19 [0.68-2.08],0.5499080051666103
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,28212,151,1.22 [0.83-1.81],0.3093505969988905
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27916,163,1.08 [0.74-1.58],0.6856167509063827
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,28208,74,1.16 [0.66-2.02],0.6105405759540037
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28148,258,0.99 [0.73-1.34],0.951372087163537
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27919,121,1.75 [1.14-2.68],0.010338649184535
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27602,1082,1.01 [0.87-1.17],0.90730732979707
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,28185,124,1.16 [0.75-1.78],0.5110042303962697
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,28302,115,1.50 [0.96-2.33],0.0738943735915857
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27801,272,0.96 [0.71-1.28],0.7604557496848952
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,28097,36,1.60 [0.73-3.53],0.2440296767600648
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,28300,38,1.23 [0.56-2.67],0.604649401576786
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27568,39,0.85 [0.40-1.83],0.681611845586859
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27649,120,0.92 [0.59-1.43],0.7186068907954901
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27632,72,0.84 [0.47-1.49],0.5484851682834819
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27811,58,1.03 [0.55-1.92],0.9363766090489865
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27611,51,0.51 [0.26-1.01],0.0526965940972305
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27949,59,0.82 [0.44-1.54],0.5445809812677631
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27983,93,1.10 [0.67-1.81],0.7042284316428573
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27622,93,0.93 [0.56-1.53],0.765975497716442
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27687,127,0.83 [0.54-1.27],0.3875518954513565
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27597,37,1.02 [0.46-2.26],0.9614445795642098
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,27367,847,0.99 [0.83-1.16],0.8597870636380593
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27579,50,1.56 [0.80-3.04],0.1914909457619395
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28108,310,1.22 [0.93-1.60],0.1545873254797314
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27836,38,0.87 [0.39-1.92],0.7329923110962366
CD300LG,CMRF35-like molecule 9,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27929,131,1.30 [0.86-1.96],0.2187654708368709
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,28128,62,1.12 [0.61-2.05],0.7176232358317356
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,28286,101,1.11 [0.69-1.78],0.6803098835738894
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,28207,140,0.70 [0.46-1.04],0.0791102585225147
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,28121,55,1.44 [0.76-2.73],0.2592317181248193
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,28121,55,0.93 [0.49-1.79],0.8360005610538861
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,28239,543,0.99 [0.80-1.22],0.9178723491736548
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,28033,337,1.05 [0.81-1.37],0.7055026262212032
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27795,99,0.90 [0.55-1.46],0.6694428136475861
CD300LG,CMRF35-like molecule 9,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27779,83,1.56 [0.93-2.62],0.0939924146036085
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute pharyngitis,28040,83,1.06 [0.63-1.78],0.8342948305856733
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28196,239,1.09 [0.80-1.48],0.5968912643465079
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,28021,64,1.13 [0.63-2.04],0.6857603139287443
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza,26978,80,2.88 [1.73-4.81],4.949396933784876e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26976,78,2.71 [1.61-4.57],0.0001750754163979
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic asthma (mode),21007,130,0.76 [0.50-1.17],0.2163984072729561
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Allergic rhinitis,28172,319,0.90 [0.69-1.18],0.4574372745595934
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22531,1801,0.97 [0.86-1.09],0.5924125802842466
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22649,1772,0.98 [0.87-1.10],0.6921332128974195
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),28032,96,2.71 [1.72-4.29],1.9550384933638025e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26955,57,3.34 [1.83-6.10],8.595688711669082e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Bronchiectasis,25220,186,1.06 [0.75-1.51],0.7404407348949384
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",25077,43,2.06 [1.01-4.19],0.0454410446886197
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,27447,2413,0.96 [0.87-1.06],0.3876065387903337
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26823,69,0.95 [0.53-1.70],0.858252397957401
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Chronic sinusitis,26927,173,0.82 [0.57-1.18],0.2795964492577547
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",28222,741,0.98 [0.82-1.17],0.8042371983079715
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Deviated nasal septum,26884,130,0.79 [0.51-1.21],0.2743054825218428
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,26377,4362,1.03 [0.96-1.11],0.3795489139230945
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27141,387,0.68 [0.53-0.87],0.002394820996218
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Early onset COPD,28004,523,0.91 [0.73-1.12],0.3607825600481654
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Emphysema,25224,190,0.73 [0.52-1.04],0.0832443610408533
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27052,113,1.53 [0.98-2.40],0.0631305855278535
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Influenza and pneumonia,28138,1240,1.30 [1.13-1.49],0.0002030569767322
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Interstitial lung disease,27078,139,1.50 [1.00-2.25],0.0472550146693264
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Later onset COPD,26856,218,1.14 [0.82-1.57],0.4390564530455333
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,28321,158,1.77 [1.22-2.57],0.002598525850158
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Nasal polyp,26871,117,1.06 [0.68-1.66],0.8042937246346877
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,28115,628,1.24 [1.02-1.49],0.0290116940529963
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of pleura,28154,1279,1.34 [1.17-1.53],1.887660856970665e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27663,909,0.80 [0.68-0.94],0.0054743866424749
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other pleural conditions,26910,35,1.78 [0.79-4.01],0.1637682959527155
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28274,202,1.76 [1.27-2.45],0.0006914901446595
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,28248,869,1.42 [1.21-1.67],2.3007051960013364e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural effusion,27487,612,1.48 [1.22-1.80],6.902026630692532e-05
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pleural plaque,26932,57,1.63 [0.86-3.09],0.1372593287004779
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27923,1025,1.29 [1.11-1.50],0.000983352220289
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,28301,138,2.10 [1.42-3.10],0.0002022592797585
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pneumothorax,26940,65,1.53 [0.84-2.79],0.1648973370446075
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pollen allergy,28293,272,0.84 [0.63-1.13],0.2562856776174033
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Pulmonary oedema,28111,39,3.07 [1.52-6.21],0.0017761132948371
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20915,38,1.37 [0.62-3.02],0.4423722120508894
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,28096,609,1.30 [1.07-1.57],0.0079148697116328
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,27073,319,0.89 [0.68-1.17],0.4204461404729332
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Viral pneumonia,27095,197,0.94 [0.67-1.33],0.7370264200415122
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",28054,171,0.88 [0.61-1.28],0.5054414618320026
CD300LG,CMRF35-like molecule 9,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16360,104,0.53 [0.32-0.86],0.0096885744067633
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21697,65,1.03 [0.56-1.89],0.9202562450130318
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute appendicitis,28124,160,1.20 [0.82-1.76],0.343446869014556
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute gastritis,22654,76,1.45 [0.84-2.52],0.1854473274941803
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute pancreatitis,26697,170,0.83 [0.57-1.21],0.3265608601928295
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Acute peritonitis,27879,75,2.56 [1.51-4.33],0.0004528367134119
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27532,85,1.37 [0.82-2.30],0.2308999863559767
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Barrett oesophagus,22937,359,0.82 [0.63-1.06],0.1338254412391644
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26585,58,1.41 [0.75-2.64],0.2832376274632454
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27907,58,1.42 [0.76-2.65],0.2778507420654268
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholecystitis,26712,185,1.22 [0.85-1.73],0.2803907273818049
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Cholelithiasis,27457,930,0.78 [0.67-0.92],0.0024515875991365
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic gastritis,22838,260,0.85 [0.63-1.15],0.3054913188595173
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26570,43,1.98 [0.99-3.97],0.054838249404221
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",28179,82,1.15 [0.68-1.96],0.6081056162464524
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Coeliac disease,26866,117,0.56 [0.36-0.87],0.0102142163594867
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Collagenous colitis,26720,60,1.24 [0.67-2.31],0.4893008785446077
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28140,214,1.04 [0.75-1.44],0.8236738099106519
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Constipation,28103,1199,1.10 [0.96-1.26],0.1818538479021186
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn disease,26758,98,1.22 [0.75-1.99],0.414446554714776
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27970,69,1.07 [0.60-1.92],0.8095718470261772
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26756,96,1.49 [0.91-2.43],0.1089910789331214
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Dental caries,27460,269,0.92 [0.68-1.23],0.5628783324621018
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,26199,1874,0.93 [0.83-1.04],0.1901752865209346
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of appendix,28168,204,1.11 [0.79-1.56],0.5385258434674935
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of liver,28207,760,1.01 [0.85-1.20],0.9094230797538968
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26586,4008,0.93 [0.86-1.00],0.0578175084570197
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27826,635,1.08 [0.89-1.31],0.4242422367132452
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28247,443,1.10 [0.88-1.39],0.3951043162274297
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27327,136,1.09 [0.72-1.65],0.6713840904027109
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of salivary glands,27159,71,1.20 [0.68-2.11],0.5364801809733917
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of the digestive system,28045,1296,1.04 [0.91-1.19],0.5694050565079125
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diseases of tongue,27171,123,1.21 [0.79-1.87],0.38287075715228
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27801,1274,0.89 [0.78-1.02],0.0893031856389651
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,24124,2492,0.89 [0.81-0.98],0.0229771292846365
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Duodenal ulcer,22724,146,0.98 [0.65-1.46],0.9106770654673008
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28258,116,0.89 [0.57-1.39],0.6092987526987595
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28188,85,1.11 [0.66-1.87],0.6874781133618795
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27551,104,1.14 [0.71-1.84],0.5758664060355588
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21818,186,1.00 [0.70-1.43],0.9952998334168832
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Functional dyspepsia,23105,527,0.76 [0.62-0.94],0.0119466812775856
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastric ulcer,22866,288,1.17 [0.88-1.55],0.2796205724812921
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24876,2298,0.85 [0.76-0.94],0.0012114026381754
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22992,414,1.14 [0.90-1.44],0.2920059249317117
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,23141,8292,0.92 [0.88-0.98],0.0043978192732614
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,GI-bleeding,27792,1043,1.07 [0.92-1.24],0.3993120132434111
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,27253,62,1.78 [0.99-3.21],0.0559619166043395
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22583,1320,0.92 [0.80-1.05],0.2173028241830185
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27503,56,1.59 [0.84-3.00],0.1539113115848429
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Hernia,27142,2817,0.91 [0.83-1.00],0.0498551320168316
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impacted teeth,28198,79,1.12 [0.65-1.92],0.6921461998139937
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Impaction of intestines,21666,34,1.18 [0.52-2.68],0.6900853870997576
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Inguinal hernia,25021,696,0.81 [0.67-0.97],0.0247388073353912
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",24406,81,0.75 [0.44-1.30],0.3098238279817991
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21707,75,1.31 [0.75-2.29],0.3473819421373042
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26887,138,0.71 [0.47-1.07],0.1047525618961337
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22224,592,1.01 [0.83-1.23],0.9370572409919338
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,28303,391,0.68 [0.53-0.87],0.0020591698608526
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27380,720,1.16 [0.97-1.39],0.101471703142048
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27571,911,1.07 [0.91-1.25],0.4383326805920203
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22732,154,1.08 [0.73-1.60],0.701701098778571
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oesophagitis,23077,499,1.08 [0.87-1.34],0.4958322751413359
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28286,136,0.93 [0.62-1.41],0.7458202295222488
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,24376,51,0.71 [0.36-1.41],0.328098235435078
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22962,1330,0.97 [0.85-1.11],0.6854868524029922
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26729,202,1.17 [0.84-1.65],0.350243137208287
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26694,167,0.72 [0.50-1.05],0.0873584110621244
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestine,23172,1540,0.93 [0.82-1.05],0.2464929961045592
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of intestines,26646,5014,0.97 [0.90-1.04],0.3668340311386761
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27165,201,0.93 [0.66-1.31],0.6684149432677968
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of liver,28060,613,0.97 [0.80-1.18],0.7544273910019034
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,23130,552,0.86 [0.70-1.06],0.149664956810417
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26614,87,1.25 [0.75-2.09],0.3984155816264675
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28189,385,0.98 [0.77-1.25],0.8733483526680161
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,23377,799,0.82 [0.69-0.97],0.0202387078984933
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27806,1057,1.09 [0.94-1.26],0.2751198653225432
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27385,194,0.84 [0.60-1.19],0.3281898043343577
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22880,1248,1.05 [0.92-1.20],0.4871736153612679
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),24413,1835,0.96 [0.86-1.08],0.5073526587247874
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27533,86,0.79 [0.47-1.33],0.3667286799411187
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27455,795,1.20 [1.01-1.42],0.0366764523783696
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21870,238,0.94 [0.69-1.29],0.7036363132311871
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28172,101,1.06 [0.66-1.72],0.800802215911109
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21990,358,1.08 [0.84-1.39],0.5628356461692428
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26891,142,1.29 [0.87-1.93],0.2089776090595954
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Recurring oral aphthae,28320,59,1.28 [0.69-2.39],0.4308861358465872
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,27208,132,1.53 [1.01-2.32],0.0430775995201933
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Toxic colitis,26692,32,3.23 [1.45-7.21],0.0042545968918193
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22770,192,0.88 [0.62-1.25],0.4705662056708489
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ulcerative colitis,26812,152,0.81 [0.55-1.20],0.2967117379339815
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26792,132,0.75 [0.49-1.15],0.1919428144375403
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Umbilical hernia,24613,288,1.01 [0.76-1.35],0.9509342464914792
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21736,104,0.83 [0.52-1.34],0.4426413767446976
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Ventral hernia,24555,230,1.07 [0.78-1.47],0.6852037434041707
CD300LG,CMRF35-like molecule 9,Chapter XI Diseases of the digestive system,Volvulus,21697,65,1.11 [0.61-2.01],0.7417307348627449
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,28273,165,1.49 [1.02-2.16],0.0373207824555032
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,28049,78,1.14 [0.66-1.95],0.6396803171096992
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26813,150,1.08 [0.73-1.60],0.7107421133638485
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27696,568,1.37 [1.12-1.68],0.0020631225604303
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27332,204,1.10 [0.79-1.55],0.5718329360634056
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26844,181,1.55 [1.09-2.21],0.0148976414857603
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,28060,233,0.96 [0.70-1.32],0.8056245709640488
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28230,403,1.14 [0.90-1.45],0.2766786719326445
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27875,48,1.72 [0.87-3.39],0.1174394173822306
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26831,2645,1.03 [0.93-1.13],0.5943232887754502
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27858,454,0.84 [0.67-1.06],0.1433966082429028
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27727,323,0.76 [0.58-0.99],0.0418142633735002
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27935,807,1.18 [1.00-1.40],0.0547872188138977
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",28317,48,0.83 [0.41-1.66],0.5915223177937625
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26720,57,1.23 [0.65-2.32],0.5166333876948359
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27445,41,0.79 [0.37-1.67],0.5310671146933577
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,28053,226,0.97 [0.70-1.33],0.8448387060950576
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26957,294,1.03 [0.77-1.36],0.8625579236489003
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26701,38,1.43 [0.66-3.13],0.3649491608784523
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,28245,67,1.29 [0.72-2.30],0.3906952195522427
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,27268,140,0.89 [0.59-1.35],0.5913906124927641
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28135,164,1.05 [0.72-1.52],0.8158503472482845
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27860,33,3.75 [1.76-8.00],0.0006154809330676
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26718,55,1.02 [0.53-1.96],0.9528679191825068
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27791,1128,1.22 [1.05-1.40],0.0075448615203922
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26988,325,0.98 [0.75-1.28],0.8898867031818539
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26705,42,1.20 [0.57-2.52],0.6380943903544645
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28246,275,1.05 [0.79-1.41],0.7278702921657445
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27891,64,1.52 [0.85-2.72],0.1621120628543814
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28198,227,1.11 [0.81-1.53],0.5125840323706483
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28296,188,1.37 [0.97-1.94],0.076880927484061
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26787,124,1.14 [0.74-1.76],0.5531537486471483
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26858,195,1.12 [0.79-1.58],0.5247687197789404
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28287,179,1.45 [1.01-2.08],0.0414319037843507
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26797,134,1.81 [1.20-2.71],0.0044552840450721
CD300LG,CMRF35-like molecule 9,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,28296,118,1.25 [0.81-1.94],0.3161026953395192
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24871,136,0.96 [0.63-1.45],0.8296970567196116
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,26452,4777,1.09 [1.01-1.17],0.0195661300611889
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,25051,3376,1.08 [0.99-1.17],0.0822192802291668
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24834,99,1.29 [0.79-2.09],0.3092229296331815
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25433,159,1.03 [0.70-1.50],0.8867962379438412
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25435,161,1.11 [0.76-1.62],0.5873567474575571
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,28097,116,1.03 [0.66-1.60],0.9000377232500197
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",25322,48,1.39 [0.70-2.76],0.3422441652186647
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22442,767,1.28 [1.07-1.53],0.0056353869341435
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28267,127,1.38 [0.90-2.10],0.137817717247186
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25576,302,1.11 [0.84-1.46],0.4736828722830993
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24784,6408,1.08 [1.02-1.15],0.009471913875838
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26922,110,2.13 [1.37-3.33],0.000869189748839
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24854,119,1.35 [0.87-2.09],0.1818421984525689
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25355,620,1.05 [0.86-1.27],0.6232812963009116
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,27420,2146,0.98 [0.89-1.09],0.7597195987120601
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24969,234,1.51 [1.10-2.07],0.0107251773703325
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,25026,291,1.30 [0.98-1.71],0.0686768895588531
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24885,150,1.07 [0.72-1.59],0.7233174627818586
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27801,36,1.30 [0.58-2.89],0.5236686442413636
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,23025,1350,1.04 [0.91-1.19],0.5589957612605492
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,22082,407,1.53 [1.20-1.95],0.0006711664867944
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28274,397,1.50 [1.17-1.92],0.001244251453495
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21748,73,0.88 [0.50-1.55],0.6538700406930121
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22030,355,1.40 [1.08-1.80],0.0096393279093906
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25073,338,1.00 [0.77-1.31],0.9815168744339132
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22464,789,1.15 [0.97-1.37],0.1053221017052458
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,25304,30,2.72 [1.20-6.14],0.0162395686026834
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25839,565,1.14 [0.94-1.40],0.1869912474314519
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25561,287,1.09 [0.82-1.45],0.5491086350524705
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22411,736,1.13 [0.94-1.35],0.1901540857070545
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24823,88,1.48 [0.89-2.45],0.1265546728524706
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24797,62,1.09 [0.59-2.01],0.7794154242824266
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26872,60,0.85 [0.45-1.59],0.6063583320848229
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27989,1177,1.48 [1.29-1.70],2.121886718338032e-08
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27481,669,1.54 [1.28-1.84],4.647741386142699e-06
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28219,355,0.94 [0.73-1.21],0.6072428366666316
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23494,1819,1.13 [1.01-1.27],0.030352590541783
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21758,83,1.45 [0.85-2.46],0.170077732585111
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24816,81,1.56 [0.92-2.64],0.0989672736173778
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21702,27,2.27 [0.90-5.72],0.0815892338325315
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21789,114,1.33 [0.85-2.09],0.2154810293287355
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27046,234,1.26 [0.92-1.73],0.1423354387583459
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,27061,249,1.59 [1.17-2.14],0.0027251859858933
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,28287,86,1.02 [0.61-1.70],0.9534407009772444
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26874,1600,1.00 [0.89-1.13],0.9865538576317252
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24859,124,1.62 [1.05-2.47],0.0273882866695661
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21792,117,1.12 [0.72-1.75],0.6204031867955078
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25925,651,1.01 [0.84-1.22],0.8980411633360279
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23771,2096,1.22 [1.10-1.36],0.0001741366921251
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27823,58,1.33 [0.71-2.49],0.3773919370448705
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,28304,74,1.09 [0.62-1.89],0.769162269576941
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24820,85,1.34 [0.80-2.25],0.2654979026775202
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25865,1130,1.25 [1.08-1.44],0.0021081408108142
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24805,70,1.58 [0.89-2.79],0.1169929150689496
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22817,1142,1.08 [0.94-1.25],0.2884442222779689
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26916,104,0.96 [0.60-1.54],0.8688401186176625
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24806,71,1.45 [0.82-2.56],0.2013489382828973
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,25393,119,0.80 [0.51-1.24],0.310113273605062
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25149,414,1.52 [1.20-1.92],0.0004271337660128
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27980,215,1.29 [0.93-1.79],0.1262307975925421
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25750,476,1.26 [1.01-1.57],0.0367590096989218
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28228,335,0.90 [0.69-1.17],0.4312333103062472
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,28311,39,0.57 [0.26-1.23],0.1519703928733877
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24946,211,1.27 [0.91-1.77],0.1591691035241602
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22757,610,1.30 [1.07-1.58],0.0077693995703359
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25246,511,1.38 [1.12-1.70],0.0026662648309699
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24911,176,1.48 [1.02-2.13],0.0373983584458974
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21712,37,2.39 [1.13-5.02],0.0217950711210607
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23485,1810,1.08 [0.97-1.21],0.1671982718711646
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,22139,464,0.94 [0.75-1.17],0.5677732326401885
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27852,87,1.24 [0.74-2.08],0.4189836239391045
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",28253,52,1.29 [0.67-2.50],0.4476283683766652
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26679,30,1.42 [0.60-3.35],0.4201796574069568
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21751,76,1.11 [0.64-1.94],0.7121113248179252
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,25368,94,0.65 [0.40-1.07],0.0908759571222004
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22034,359,0.92 [0.72-1.19],0.5443463560447892
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25011,276,1.07 [0.80-1.43],0.6655367453625799
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25494,220,0.83 [0.60-1.14],0.2527791157360496
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,25383,109,1.32 [0.84-2.08],0.2331948166755288
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,24006,48,0.95 [0.47-1.91],0.8868335070695718
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",28314,42,0.61 [0.29-1.29],0.1940177539783834
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25355,620,1.02 [0.84-1.24],0.8404653429338879
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27856,91,1.78 [1.09-2.93],0.0218370585755697
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,27213,2478,1.18 [1.07-1.30],0.0008082893193855
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24847,112,0.96 [0.61-1.52],0.8765811494144291
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25634,360,0.92 [0.71-1.19],0.5317704829162516
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26897,190,0.82 [0.58-1.16],0.2668403328491668
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,25431,157,1.06 [0.72-1.55],0.7615074960609656
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,26355,1081,0.95 [0.83-1.10],0.5354280423186912
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25994,720,0.99 [0.83-1.19],0.9292216939595184
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24781,46,1.24 [0.62-2.49],0.542650802099694
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27914,149,1.14 [0.77-1.68],0.5208693896762092
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24895,160,0.66 [0.45-0.97],0.034260060501728
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24795,60,1.32 [0.71-2.43],0.3771092538061802
CD300LG,CMRF35-like molecule 9,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21714,39,1.16 [0.53-2.53],0.7131685704026697
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27759,887,1.99 [1.69-2.34],2.2046952424045247e-16
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11508,74,0.85 [0.49-1.48],0.5603977868048633
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15298,78,1.09 [0.64-1.87],0.756220975490147
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28024,334,0.72 [0.55-0.94],0.0155191115586303
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27753,63,0.80 [0.43-1.48],0.4743792895055112
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27582,710,4.92 [4.14-5.85],6.870851151704947e-73
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,28135,32,21.32 [11.70-38.85],1.6363028020582598e-23
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,28148,194,1.13 [0.80-1.61],0.4774982670040324
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Cystitis,26051,169,0.74 [0.51-1.07],0.1137028868943851
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Dialysis,26931,59,2.52 [1.95-3.26],1.9406145465928107e-12
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12236,1156,0.98 [0.85-1.14],0.8315619063622222
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15429,209,0.85 [0.61-1.19],0.3454767791439154
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Endometriosis,11573,139,0.91 [0.61-1.37],0.6557563807386977
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11829,395,0.74 [0.58-0.94],0.0132849866982268
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11871,437,0.59 [0.47-0.75],8.365004919585205e-06
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23896,4399,0.99 [0.92-1.06],0.7209262866521451
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,28173,70,4.79 [2.84-8.07],4.1402984876717045e-09
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydrocele,11169,89,0.98 [0.58-1.65],0.9277447831817016
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26790,237,0.96 [0.70-1.33],0.8186358613649682
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11846,766,0.95 [0.79-1.13],0.5421704646699296
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15286,249,0.81 [0.60-1.10],0.1734706710802391
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11188,108,0.81 [0.50-1.30],0.3784483241392365
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Irregular menses,15296,128,0.70 [0.46-1.08],0.1051555633197125
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11736,302,0.74 [0.56-0.97],0.0305695918992265
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25952,70,1.16 [0.65-2.06],0.6204260220092632
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12887,1453,0.80 [0.71-0.91],0.0005158627108331
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,11128,48,0.81 [0.39-1.65],0.5573538862456227
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11539,105,0.98 [0.62-1.57],0.9459216883261454
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",28317,41,0.72 [0.34-1.53],0.3949478671536958
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",28324,49,0.34 [0.17-0.68],0.0020420957639471
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27437,1555,1.00 [0.88-1.13],0.9897408055172072
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26370,488,0.87 [0.69-1.08],0.1982259124811606
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15289,69,0.56 [0.32-1.00],0.0490372137932126
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28278,324,1.60 [1.22-2.08],0.0005650537089616
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11235,155,1.66 [1.13-2.46],0.0106681213643076
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11200,120,0.71 [0.45-1.13],0.1469563463925125
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,11156,76,0.65 [0.37-1.16],0.1455431908978117
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,28290,53,1.60 [0.84-3.05],0.1552178314313202
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,27005,1123,1.08 [0.93-1.24],0.318222917562686
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15166,129,1.00 [0.66-1.52],0.9937248447401812
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11523,89,0.69 [0.41-1.15],0.1511324210148308
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11670,236,0.64 [0.47-0.88],0.0053562956775383
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11495,61,0.76 [0.41-1.40],0.3723220733710113
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11540,106,0.77 [0.48-1.23],0.2706669945098628
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26823,270,1.18 [0.88-1.60],0.2711395924698681
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,28068,114,1.60 [1.02-2.50],0.0411648282463891
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11618,184,0.83 [0.58-1.19],0.3129289250006832
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11517,83,1.10 [0.65-1.86],0.734504909078296
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11881,447,0.78 [0.63-0.98],0.0361305646956217
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11505,71,0.80 [0.45-1.41],0.4342030250166077
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11827,393,0.66 [0.52-0.84],0.0007590446019126
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,28151,48,2.51 [1.29-4.92],0.0070549420839077
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11189,109,1.17 [0.73-1.88],0.513792158815735
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,28124,1571,1.89 [1.68-2.14],1.691797662068876e-24
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26697,144,2.49 [1.67-3.73],8.808925048704235e-06
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26951,79,8.25 [4.97-13.69],3.1566948937679875e-16
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27763,73,0.88 [0.50-1.56],0.6718206785294767
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26053,171,1.02 [0.70-1.47],0.9302846411268144
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28089,399,0.75 [0.59-0.96],0.0220727074853718
CD300LG,CMRF35-like molecule 9,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11542,108,0.57 [0.36-0.90],0.0161459281082817
